Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy-Reference-Cited by-同舟云学术

Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy

Published:2010-10 Issue:15 Volume:46 Page:2746-2752
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Santoro Armando,Rimassa Lorenza,Sobrero Alberto F.,Citterio Giovanni,Sclafani Francesco,Carnaghi Carlo,Pessino Anna,Caprioni Francesco,Andretta Valeria,Tronconi Maria Chiara,Finocchiaro Giovanna,Rossoni Gloria,Zanoni Angela,Miggiano Chiara,Rizzardi Gian-Paolo,Traversari Catia,Caligaris-Cappio Federico,Lambiase Antonio,Bordignon Claudio

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. An endotoxin-induced serum factor that causes necrosis of tumors;Carswell;Proc Natl Acad Sci USA,1975

2. Efficiency of recombinant human TNF in human cancer therapy;Lejeune;Cancer Immun,2006

3. A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days;Creaven;Cancer Chemother Pharmacol,1989

4. Phase I trial of recombinant human tumour necrosis factor alpha in patients with advanced malignancy;Gamm;Eur J Cancer,1991

5. Phase I study of recombinant human tumor necrosis factor;Kimura;Cancer Chemother Pharmacol,1987

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the Blood–Brain Tumor Barrier with Tumor Necrosis Factor-α;Pharmaceutics;2022-07-06

2. Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery;New Journal of Chemistry;2021

3. A systematic review of salvage therapies in refractory metastatic colorectal cancer;International Journal of Colorectal Disease;2020-03-26

4. Hyperthermic intraperitoneal chemotherapy with recombinant mutant human TNF-α and raltitrexed in mice with colorectal-peritoneal carcinomatosis;Experimental Biology and Medicine;2020-02-10

5. Targeted Delivery of TNF Potentiates the Antibody-Dependent Cell-Mediated Cytotoxicity of an Anti-Melanoma Immunoglobulin;Journal of Investigative Dermatology;2019-06